• 011-26907444
  • raghava@iiitd.ac.in

Welcome to Peptide Card of AntiTbPdb

This page displays user query in tabular form.

RKDVYRRRRRR details
Primary information
ID antitb_1609,
Name24411680
N-Terminal modificationRR-11
C-Terminal ModificationRKDVYRRRRRR
Chemical ModificationFree
Linear/CyclicAmidation
LengthNone
ChiralityLinear
Nature10
SourceL
OriginCationic
SpeciesSynthetic
Inhibition ConcentrationMycobacterium smegmatis
In Vitro/ In vivoMycobacterium smegmatis RIF-susceptible
Cell LineMIC = 125 mg/L
Inhibition Concentrationin vitro
Sequence2014
CytotoxicityRAW 264.7 mouse macrophage
In vivo ModelNA
Lethal DoseHC50= > 2000 mg/L on Human RBC
Immune ResponceNA
Mechanism of ActionNA
TargetStimulate TNF-α production
Combination TherapyDisrupt the mycobacterial membrane
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1613,
Name24411680
N-Terminal modificationRR-11
C-Terminal ModificationRKDVYRRRRRR
Chemical ModificationFree
Linear/CyclicAmidation
LengthNone
ChiralityLinear
Nature10
SourceL
OriginCationic
SpeciesSynthetic
Inhibition ConcentrationMycobacterium smegmatis
In Vitro/ In vivoMycobacterium smegmatis RIF-Resistance
Cell LineMIC = 125 mg/L
Inhibition Concentrationin vitro
Sequence2014
CytotoxicityRAW 264.7 mouse macrophage
In vivo ModelNA
Lethal DoseHC50= > 2000 mg/L on Human RBC
Immune ResponceNA
Mechanism of ActionNA
TargetStimulate TNF-α production
Combination TherapyDisrupt the mycobacterial membrane
Other activitiesNA
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),